January 6, 2026 · Form 4 insider transaction
Borgeson Blake sold 220,000 shares of Recursion Pharmaceuticals Inc at $4.36 per share, a transaction worth $959.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.